The latest price target for Omega Healthcare Invts (NYSE:OHI) was reported by BMO Capital on December 9, 2024. The analyst firm set a price target for $45.00 expecting OHI to rise to within 12 months (a possible 19.02% upside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for Omega Healthcare Invts (NYSE:OHI) was provided by BMO Capital, and Omega Healthcare Invts upgraded their outperform rating.

The last upgrade for Omega Healthcare Investors Inc happened on December 9, 2024 when BMO Capital raised their price target to $45. BMO Capital previously had a market perform for Omega Healthcare Investors Inc.

The last downgrade for Omega Healthcare Investors Inc happened on January 16, 2024 when B of A Securities changed their price target from $33 to $31 for Omega Healthcare Investors Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omega Healthcare Invts, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omega Healthcare Invts was filed on December 9, 2024 so you should expect the next rating to be made available sometime around December 9, 2025.

While ratings are subjective and will change, the latest Omega Healthcare Invts (OHI) rating was a upgraded with a price target of $45.00 to $45.00. The current price Omega Healthcare Invts (OHI) is trading at is $37.81, which is out of the analyst’s predicted range.